Free Trial

Castle Biosciences (CSTL) Competitors

Castle Biosciences logo
$26.15 -4.10 (-13.55%)
As of 01/13/2025 04:00 PM Eastern

CSTL vs. BTSG, LFST, SGRY, CON, PRVA, WGS, ARDT, ADUS, PACS, and FTRE

Should you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), PACS Group (PACS), and Fortrea (FTRE). These companies are all part of the "healthcare" industry.

Castle Biosciences vs.

Castle Biosciences (NASDAQ:CSTL) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings.

Castle Biosciences received 66 more outperform votes than BrightSpring Health Services when rated by MarketBeat users. However, 89.29% of users gave BrightSpring Health Services an outperform vote while only 65.00% of users gave Castle Biosciences an outperform vote.

CompanyUnderperformOutperform
Castle BiosciencesOutperform Votes
91
65.00%
Underperform Votes
49
35.00%
BrightSpring Health ServicesOutperform Votes
25
89.29%
Underperform Votes
3
10.71%

92.6% of Castle Biosciences shares are held by institutional investors. 7.2% of Castle Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Castle Biosciences has a net margin of 1.95% compared to BrightSpring Health Services' net margin of -0.38%. BrightSpring Health Services' return on equity of 4.16% beat Castle Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Castle Biosciences1.95% 1.47% 1.27%
BrightSpring Health Services -0.38%4.16%0.99%

Castle Biosciences presently has a consensus price target of $40.29, indicating a potential upside of 54.06%. BrightSpring Health Services has a consensus price target of $18.65, indicating a potential upside of 7.95%. Given Castle Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Castle Biosciences is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Castle Biosciences
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.93

Castle Biosciences has higher earnings, but lower revenue than BrightSpring Health Services. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Castle Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Castle Biosciences$311.88M2.35-$57.47M$0.20130.75
BrightSpring Health Services$10.59B0.28-$154.60M-$0.26-66.46

In the previous week, Castle Biosciences had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 20 mentions for Castle Biosciences and 4 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.40 beat Castle Biosciences' score of 0.63 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Castle Biosciences
5 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Castle Biosciences beats BrightSpring Health Services on 12 of the 17 factors compared between the two stocks.

Get Castle Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CSTL vs. The Competition

MetricCastle BiosciencesMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$847.21M$2.99B$5.31B$8.83B
Dividend YieldN/A15.49%5.07%4.00%
P/E Ratio130.7615.6586.5916.80
Price / Sales2.35242.751,070.46115.83
Price / CashN/A459.6343.2437.79
Price / Book1.805.165.094.88
Net Income-$57.47M-$33.85M$122.01M$228.12M
7 Day Performance-18.71%-6.38%-3.79%-3.81%
1 Month Performance-9.42%-6.35%0.14%0.01%
1 Year Performance30.55%8.32%25.24%13.15%

Castle Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CSTL
Castle Biosciences
3.3285 of 5 stars
$26.15
-13.6%
$40.29
+54.1%
+30.6%$847.21M$311.88M130.76540News Coverage
High Trading Volume
BTSG
BrightSpring Health Services
2.243 of 5 stars
$17.27
-2.1%
$18.65
+8.0%
N/A$3.01B$10.59B-66.4235,000Positive News
LFST
LifeStance Health Group
2.0298 of 5 stars
$7.63
-2.7%
$8.70
+14.0%
+12.8%$2.92B$1.21B-29.359,325Short Interest ↓
Positive News
SGRY
Surgery Partners
2.5038 of 5 stars
$20.35
-3.5%
$36.56
+79.6%
-34.8%$2.59B$2.99B-42.4012,200
CON
Concentra Group Holdings Parent
N/A$19.53
-0.4%
$28.50
+45.9%
N/A$2.49B$1.88B0.0011,000Positive News
Gap Down
PRVA
Privia Health Group
3.5342 of 5 stars
$20.15
+1.0%
$24.88
+23.4%
-2.4%$2.40B$1.72B201.521,102
WGS
GeneDx
1.4956 of 5 stars
$86.16
+8.9%
$59.33
-31.1%
+2,222.7%$2.37B$267.23M-27.701,200
ARDT
Ardent Health Partners
N/A$16.12
-3.1%
$22.00
+36.5%
N/A$2.30B$5.71B0.0024,200Lockup Expiration
ADUS
Addus HomeCare
4.5882 of 5 stars
$124.02
-0.5%
$133.67
+7.8%
+45.2%$2.25B$1.13B28.3833,200Positive News
PACS
PACS Group
3.3183 of 5 stars
$13.54
+1.4%
$34.00
+151.1%
N/A$2.06B$3.56B0.0032,433
FTRE
Fortrea
2.9989 of 5 stars
$19.69
+2.1%
$23.30
+18.3%
-40.4%$1.77B$3.11B-5.7618,000Short Interest ↑

Related Companies and Tools


This page (NASDAQ:CSTL) was last updated on 1/14/2025 by MarketBeat.com Staff
From Our Partners